oseltamivir has been researched along with Nervous System Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, A; Okamura, M; Ono, H | 1 |
| Falahee, ML; Vallerand, AH; Vantine, M | 1 |
| Abughali, N; Abzug, MJ; Bradley, JS; Cloud, GA; Englund, J; Griffin, J; Guzman-Cottrill, J; Jacobs, RF; Jester, P; Kimberlin, DW; Lang, D; Leach, C; Ramilo, O; Robinson, J; Romero, JR; Shalabi, M; Shelton, M; Storch, G; Wade, KC; Whitley, RJ | 1 |
| Calitri, C; Cuozzo, M; Gabiano, C; Garazzino, S; Pinon, M; Scolfaro, C; Tovo, PA; Zoppo, M | 1 |
| Chang, TP; Chen, YC; Lo, CP | 1 |
| Dabscheck, G; Johnston, H; McMullan, B; Rawlinson, W; Robertson, P; Walls, T | 1 |
| Armano, R; Blumental, S; Cornet, MC; De Schutter, I; Ferreiro, C; Fonteyne, C; Hermans, D; Huisman, E; Kabamba-Mukadi, B; Lepage, P; Levy, J; Mahadeb, B; Malfroot, A; Moulin, D; Nassogne, MC; Reynders, M; Van Berlaer, G; Vergison, A; Wybo, I | 1 |
| Benjamin, JH; Gardner, C; Green, K; Lee, W; Loeb, M; McArthur, M; McGeer, AJ; Simor, AE | 1 |
| Nau, JY | 1 |
| Maxwell, SR | 1 |
12 other study(ies) available for oseltamivir and Nervous System Disorders
| Article | Year |
|---|---|
[Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)].
Topics: Amantadine; Antiviral Agents; Dopamine Agonists; Drug Labeling; Enzyme Inhibitors; Humans; Influenza, Human; Mental Disorders; Molecular Conformation; Nervous System Diseases; Neuraminidase; Nicotinic Antagonists; Oseltamivir | 2018 |
Neuropsychiatric concerns related to influenza treatment.
Topics: Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mental Disorders; Nervous System Diseases; Oseltamivir; Zanamivir | 2009 |
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
Topics: Adamantane; Antiviral Agents; Central Nervous System; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Retrospective Studies; Rimantadine | 2010 |
Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.
Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Lung Diseases; Male; Medical Records; Nervous System Diseases; Oseltamivir; Treatment Outcome | 2010 |
Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features--a case report.
Topics: Acyclovir; Adult; Anti-Bacterial Agents; Antiviral Agents; Brain; Cerebral Angiography; Electroencephalography; Encephalitis; Hemiplegia; Humans; Hypnotics and Sedatives; Influenza A Virus, H1N1 Subtype; Influenza, Human; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Muscle Rigidity; Nervous System Diseases; Oseltamivir; Propofol; Tomography, X-Ray Computed; Tremor | 2010 |
Pandemic (H1N1) 2009 influenza with neurological complications diagnosed using specific serology with the haemagglutinin inhibition assay.
Topics: Adolescent; Antibodies, Viral; Anticonvulsants; Antiviral Agents; Child; Female; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Immunoenzyme Techniques; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Methylprednisolone; Nervous System Diseases; Oseltamivir; Serologic Tests; Status Epilepticus; Treatment Outcome | 2011 |
Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey.
Topics: Adolescent; Age Distribution; Anti-Bacterial Agents; Antiviral Agents; Belgium; Child; Child, Hospitalized; Child, Preschool; Critical Care; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Pandemics; Respiratory Tract Diseases; Survival Analysis | 2011 |
Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Child; Comorbidity; Developmental Disabilities; Disease Outbreaks; Female; Gastrointestinal Diseases; Humans; Incidence; Infection Control; Long-Term Care; Male; Middle Aged; Nervous System Diseases; Ontario; Oseltamivir; Respiratory Tract Infections; Severity of Illness Index | 2004 |
Oseltamivir: cutaneous and neurological adverse effects in children.
Topics: Adolescent; Adult; Animals; Antiviral Agents; Child; Europe; Humans; Influenza, Human; Nervous System Diseases; Oseltamivir; Rats; Skin Diseases; Suicide; Treatment Outcome; United States | 2006 |
[Tamiflu, suicides and seasonal influenza].
Topics: Animals; Antiviral Agents; Birds; Disease Outbreaks; France; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Japan; Nervous System Diseases; Oseltamivir; Seasons; Suicide | 2007 |
Tamiflu and neuropsychiatric disturbance in adolescents.
Topics: Adolescent; Antiviral Agents; Child; Humans; Influenza, Human; Nervous System Diseases; Oseltamivir | 2007 |
Oseltamivir: neuropsychiatric disorders.
Topics: Adolescent; Adult; Child; Child, Preschool; France; Humans; Influenza, Human; Japan; Mental Disorders; Nervous System Diseases; Oseltamivir; Suicide; United States | 2007 |